Case Study – University of Sassari
University of Sassari adopts SOPHiA DDM™ for SARS-CoV-2 research and surveillance
Country
Italy
Research Challenge
SARS-CoV-2 Surveillance
Solution
SOPHiA DDM™ Platform
The University Hospital of Sassari, established in 2007, offers a single, coordinated healthcare service as well as training and research opportunities.
Challenge
The University Hospital of Sassari is a regional reference center that diagnoses, tracks and reports SARS-CoV-2 infections. During the pandemic, the Microbiology and Virology Division needed to identify new and emerging COVID-19 strains as well as manage thousands of viral genome analyses.
Solution
“When the pandemic hit, we quickly needed a solution to analyze thousands of COVID-19 samples. In addition to the demands of the lab work, when you consider the number of analyses to do, you really need amazing computational power or services, which we didn’t have available in the lab,” said Dr. Gabriele Ibba, Medical Biologist at University Hospital of Sassari. “With SOPHiA DDM™ [platform], I can simply upload the FASTQ files and use my laptop to analyze the many samples we have, and I had the results quickly.” The SOPHiA DDM™ platform offers intuitive features for data analyses, including the SARS-CoV-2 variant table, to enable users to identify the variants of concern and compare different strains present in their samples easily and quickly.
“Even with the vaccination efforts, it remains pertinent to know which strain is circulating in the territory right now,” said Dr. Ibba. “When we get this information using the platform, we can then communicate the data to our public health authorities.”
SOPHiA GENETICS provides support through the entire workflow to meet each laboratory’s unique needs, reducing turnaround time of analyses and enabling users to gain more insights into SARS-CoV-2 whole genome analyses.
Results
The University Hospital of Sassari has successfully implemented analytical methods to track and characterize the spread of COVID-19 through the population, which remains crucial as strains escape under the selective pressure of the steadily growing number of vaccinated individuals. They have been able to identify variants of concern with robust SARS-CoV-2 genome analyses, and perform retrospective studies to better calculate the geotemporal dissemination of B.1.1.7 SARS-CoV-2 variants in north Sardinia.
“SOPHiA DDM™ [platform] saves us a massive amount of time for the analyses, letting us focus on interpreting the data only. With such a small population in Sardinia, we can gain significant insights with the platform, ultimately helping us to better understand the mechanisms that facilitate the entry of the virus in a region.”
Dr. Gabriele Ibba
Medical Biologist at the University Hospital of Sassari
Related Case Studies
Genomic Diagnostics, Australia
Genomic Diagnostics improve equity of access to hereditary cancer genomic analysis in Australia with the SOPHiA DDM™ Hereditary Cancer Solution v1.1.
TomaLab Advanced Biomedical Assays
A Clinical Case Study about the value of the SOPHiA DDM™ HRD Dx Solution in clinical routine
The Andalusian Health Service use the CE IVD-marked SOPHiA DDM™️ Dx Hereditary Cancer Solution to detect an Alu insertion (Clinical Decision Support Only) in an ovarian cancer case
The SOPHiA DDM™️ Platform enables the quick and confident assessment of ~1000 hereditary cancer samples per year.
The Andalusian Health Service address a colorectal cancer case with the CE IVD-marked SOPHiA DDM™️ Dx Hereditary Cancer Solution
The CNV detection algorithm in SOPHiA DDM™️ efficiently identified a complex duplication in MSH2.
Ontario Group of Hospitals use a future-proof custom SOPHiA DDM™ Comprehensive Hereditary Cancer Solution to be in line with Ontario guidelines.
Hospitals maximize efficiency of their laboratory workflow, fulfil updated Ontario guidelines and keep testing in-house.
The Andalusian Health Service conduct trio analysis with the SOPHiA DDM™ Platform to identify the underlying cause of 2 neonatal deaths
The SOPHiA DDM Platform was a very useful tool for resolving this complex case.
Motol University Hospital in Prague discover a novel cause of inherited cardiac disease with the SOPHiA Clinical Exome Solution v3
The laboratory finds the community frequency tool very useful for making quick decisions about whether to deeply investigate a variant.
Collaborating with the Bambino Gesù Children’s Hospital to develop the SOPHiA Nephropathies Solution
SOPHiA DDM™ enables the laboratory to process a large number of samples in a simple way to gain exhaustive insights.
DASA leverages on the SOPHiA GENETICS multimodal approach in the fight against cancer
SOPHiA GENETICS is Dasa’s partner of choice for data-driven medicine utilizing a multimodal data approach and SOPHiA DDM Trial Match.
Indian research hospital chose SOPHiA DDM™ for the analysis of gene fusion events
SOPHiA DDM™’s unique community frequency tool helps to assess solid tumor variant frequency in the hospital’s cohort and globally.